Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Towards a Better Understanding of Computational Models for Predicting DNA Methylation Effects at the Molecular Level.

Proctor NK, Ertan-Bolelli T, Bolelli K, Taylor EW, Chiu NHL, Bowen JP.

Curr Top Med Chem. 2020 Feb 25. doi: 10.2174/1568026620666200226110019. [Epub ahead of print]

PMID:
32101127
2.

Synthesis and molecular docking studies of some novel antimicrobial benzamides.

Acar C, Yalçın G, Ertan-Bolelli T, Kaynak Onurdağ F, Ökten S, Şener F, Yıldız İ.

Bioorg Chem. 2020 Jan;94:103368. doi: 10.1016/j.bioorg.2019.103368. Epub 2019 Oct 28.

PMID:
31699395
3.

4-Thiazolidinone Derivatives as MMP Inhibitors in Tissue Damage: Synthesis, Biological Evaluation and Docking Studies.

Incerti M, Crascì L, Vicini P, Aki E, Yalcin I, Ertan-Bolelli T, Cardile V, Graziano ACE, Panico A.

Molecules. 2018 Feb 14;23(2). pii: E415. doi: 10.3390/molecules23020415.

4.

Biological evaluation and pharmacophore modeling of some benzoxazoles and their possible metabolites.

Zilifdar F, Foto E, Ertan-Bolelli T, Aki-Yalcin E, Yalcin I, Diril N.

Arch Pharm (Weinheim). 2018 Feb;351(2). doi: 10.1002/ardp.201700265. Epub 2018 Jan 23.

PMID:
29359805
5.

Determination of the Apoptotic Effect and Molecular Docking of Benzamide Derivative XT5 in K562 Cells.

Ozkan T, Hekmatshoar Y, Ertan-Bolelli T, Hidayat AN, Beksac M, Aki-Yalcin E, Yalcin I, Sunguroglu A.

Anticancer Agents Med Chem. 2018;18(11):1521-1530. doi: 10.2174/1871520618666171229222534.

PMID:
29298654
6.

Design and synthesis of 2-substituted-5-(4-trifluoromethylphenyl-sulphonamido)benzoxazole derivatives as human GST P1-1 inhibitors.

Ertan-Bolelli T, Bolelli K, Musdal Y, Yildiz I, Aki-Yalcin E, Mannervik B, Yalcin I.

Artif Cells Nanomed Biotechnol. 2018 May;46(3):510-517. doi: 10.1080/21691401.2017.1324464. Epub 2017 May 14.

PMID:
28503938
7.

Antitumor activities on HL-60 human leukemia cell line, molecular docking, and quantum-chemical calculations of some sulfonamide-benzoxazoles.

Oksuzoglu E, Ertan-Bolelli T, Can H, Tarhan M, Ozturk K, Yildiz I.

Artif Cells Nanomed Biotechnol. 2017 Nov;45(7):1388-1396. doi: 10.1080/21691401.2016.1241796. Epub 2016 Nov 10.

PMID:
27829297
8.

Generated 3D-common feature hypotheses using the HipHop method for developing new topoisomerase I inhibitors.

Ataei S, Yilmaz S, Ertan-Bolelli T, Yildiz I.

Arch Pharm (Weinheim). 2015 Jul;348(7):498-507. doi: 10.1002/ardp.201500045. Epub 2015 Apr 27.

PMID:
25914208
9.

Synthesis and biological evaluation of 2-substituted-5-(4-nitrophenylsulfonamido)benzoxazoles as human GST P1-1 inhibitors, and description of the binding site features.

Ertan-Bolelli T, Musdal Y, Bolelli K, Yilmaz S, Aksoy Y, Yildiz I, Aki-Yalcin E, Yalcin I.

ChemMedChem. 2014 May;9(5):984-92. doi: 10.1002/cmdc.201400010. Epub 2014 Mar 26.

PMID:
24677708
10.

IR, Raman and SERS spectra of 2-phenoxymethylbenzothiazole.

Panicker CY, Varghese HT, Raj A, Raju K, Ertan-Bolelli T, Yildiz I, Temiz-Arpaci O, Granadeiro CM, Nogueira HI.

Spectrochim Acta A Mol Biomol Spectrosc. 2009 Sep 15;74(1):132-9. doi: 10.1016/j.saa.2009.05.022. Epub 2009 May 23.

PMID:
19524483

Supplemental Content

Loading ...
Support Center